Anaheim Bio
Anaheim Bio is unlocking the power of small molecules to transform disease and improve patients' lives.
$44.9M Series A ·
Source: finsmes.com
Funding history ↓Signals
Website registeredAug 14, 2026 (3 months old)
Funding rounds
- Series A · $44.9MSource: finsmes.com
- Website created
Companies like Anaheim Bio
JJnana Therapeutics$107M Series B+ · Nov 2022
MMatchpoint Therapeutics$150M Series B+ · Oct 2026
RRougeTx$58M Series A · Oct 2026
RRevier Therapeutics$6.95M Seed · Aug 2026
SStorm Therapeutics$56M Series B+ · Apr 2026
PProtego$130M Series B+ · Dec 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/anaheim-bio (get a free API key).